People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Other Health Care, Healthtech, Other, Pharma, Software / Tech, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Calyxo, Inc. | — | Other Health Care | Series C | $115.9M | $204.9M | 2018 |
| Solenic Medical, Inc. | — | Healthtech | Seed | $9.5M | $17.2M | 2020 |
| Akeso Biomedical, Inc. | — | Other | Series A | $5.7M | $7.3M | 2014 |
| CardioWise, Inc. | — | Other Health Care | Seed | $4.8M | $8.0M | 2014 |
| Sfc Fluidics Inc. | — | Other | Pre-Seed | $2.8M | $571K | 2012 |
| Nob Hill Therapeutics, Inc. | — | Pharma | Seed | $2.3M | $8.0M | 2021 |
| Vixiar Medical, Inc. | — | Healthtech | Seed | $1.7M | $43.8M | 2013 |
| VIN-Holdings, LLC | — | Other | Pre-Seed | $1.6M | $819K | 2024 |
| VIC Technology Venture Development, LLC | — | Software / Tech | Pre-Seed | $1.5M | $1.9M | 2013 |
| Ascendant Diagnostics, L.L.C. | — | Other | Pre-Seed | $1.0M | $18.4M | 2013 |
| Tesseract Structural Innovations, Inc. | — | Other | Pre-Seed | $788K | $1.4M | 2021 |
| Sevo Nutraceuticals, Inc. | — | Other | Pre-Seed | $748K | $2.3M | 2012 |
| NanoWatt Design, Inc. | — | Other | Pre-Seed | $690K | $3.4M | 2012 |
| Solaris Vaccines, Inc. | — | Biotech / Pharma | Pre-Seed | $610K | $1.0M | 2021 |
| Zebra Analytix, Inc. | — | Other | Pre-Seed | $518K | $3.0M | 2019 |
| Neurexis Therapeutics, Inc. | — | Pharma | Pre-Seed | $500K | $16.1M | 2021 |
| TiFiber, Inc. | — | Other | Pre-Seed | $414K | $4.1M | 2012 |
| Filtravate, Inc. | — | Other | Pre-Seed | $250K | $4.1M | 2021 |
| Vin-7 Solenic Medical, Llc | — | Healthtech | Pre-Seed | $244K | $8.4M | 2019 |
| VIN-42 Enhance Diagnostics, LLC | — | Medical Devices | Pre-Seed | $230K | $1.2M | 2024 |
| VIN-28 Solaris Vaccines, LLC | — | Biotech / Pharma | Pre-Seed | $185K | $4.4M | 2021 |
| VIN-6 Zebra Analytix, LLC | — | Other | Pre-Seed | $169K | $3.9M | 2017 |
| VIN-8 Filtravate, LLC | — | Other | Pre-Seed | $169K | $3.9M | 2020 |
| VIN-16 Neurexis Therapeutics, LLC | — | Pharma | Pre-Seed | $130K | $5.6M | 2020 |
| VIN-31 Cellia Science, LLC | — | Other | Pre-Seed | $105K | $1.2M | 2022 |
Robert Calvin Goforth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Calvin Goforth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.